ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016

IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation.

Zhuonan Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.